# US 2021/0277013 A1 · Process for the preparation of remimazolam and solid state forms of remimazolam salts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277013 A1
- Document ID: US20210277013A1
- Status: Published application
- Kind: A1
- Application number: 17/328,146
- Filed: 2021-05-24
- Published: 2021-09-09
- Earliest claimed: 2017-02-09
- Assignees: Watson Laboratories, Inc.
- Applicants: Watson Laboratories Inc.
- Inventors: Dolitzky Ben-Zion; Mendelovici Marioara; Bodkhe Arjun Rajaram; Mane Ganesh Shivaji; Samala Rajamouli Srihari; Joshi Ashutosh Vijay; Parven Kumar Luthra; Amit Singh; Anantha Rajmohan Muthusamy
- Web page: https://patentgrep.com/patent/US20210277013A1

## CPC

- C07D 487/04: Ortho-condensed systems
- A61P 23/00: Anaesthetics
- C07D 405/14: containing three or more hetero rings
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present disclosure relates to novel processes for the preparation of short acting benzodiazepines as well as to novel intermediates in this process. More particularly the disclosure relates to processes and intermediates for preparation of Methyl 3-[(4S)-8-bromo-1-methyl-6-(pyridin-2-yl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate, commonly known as Remimazolam. The present disclosure also relates to solid state forms of Remimazolam salts, processes for the preparation thereof, pharmaceutical formulations/compositions thereof, and methods of use thereof.

## Claims

### Claim at position 1

1-21. (canceled)

### Claim 22

A process for preparation of Remimazolam, comprising preparing compound IIIA of the following formula:
and converting it to Remimazolam.

### Claim 23

A process for preparation of compound IA of the following formula:
wherein R3 and R4 are independently H, alkyl, acyl, vinyl or allyl,
X is any halogen,
Y is O, S or N, or Y is NR5 wherein R5 is H, alkyl, acyl, vinyl or allyl, and
A is alkyl or aliphatic, aromatic or heterocyclic ring;
said process comprising:
a. reacting a compound of formula IV-A:
and an amino ketal compound in presence of a carbonyl activating group to obtain a compound of formula III-A:
and
b. converting the compound of formula III-A to the compound of formula I-A by deprotecting the ketal followed by cyclization in acidic condition.

### Claim 24 (depends on 23)

The process according to claim 23, further comprising converting the compound of formula IA to Remimazolam.

### Claim 25 (depends on 23)

The process according to claim 23, wherein the amino ketal compound is selected from (2-methyl-1,3-dioxolan-2-yl)methanamine, (2,5,5-trimethyl-1,3-dioxan-2-yl)methanamine or 1-amino-2,2-dimethoxypropane.

### Claim 26 (depends on 23)

The process according to claim 23, wherein the carbonyl activating group is selected from triflic anhydride, triflic acid, benzene sulfonic acid, Toluene sulfonic acid, or Methane sulfonic acid.

### Claim 27 (depends on 23)

The process according to claim 23, wherein the process is a one-pot process.

### Claim 28

A process for preparation of Remimazolam comprising:
a. reacting a compound of formula IV:
and an amino ketal compound in presence of a carbonyl activating group to obtain a compound of formula III:
and
b. converting the compound of formula III to Remimazolam by deprotecting the ketal followed by cyclization in acidic conditions.

### Claim 29 (depends on 28)

The process according to claim 28, wherein the amino ketal compound is selected from (2-methyl-1,3-dioxolan-2-yl)methanamine, (2,5,5-trimethyl-1,3-dioxan-2-yl)methanamine or 1-amino-2,2-dimethoxypropane.

### Claim 30 (depends on 28)

The process according to claim 28, wherein the amino ketal is 2-methyl-1,3-dioxolan-2-yl)methanamine.

### Claim 31 (depends on 28)

The process according to claim 28, wherein the carbonyl activating group is selected from triflic anhydride, triflic acid, benzene sulfonic acid, Toluene sulfonic acid, or Methane sulfonic acid.

### Claim 32 (depends on 28)

The process according to claim 28, wherein the process is a one-pot process.

### Claim 33

A process for preparation of Remimazolam comprising:
a. reacting a compound of formula IV:
and an amino ketal in presence of a carbonyl activating group to obtain a compound of formula III-13:
and
b. converting the compound of formula III-13 to Remimazolam, by deprotecting the ketal followed by cyclization in acidic conditions.

### Claim 34 (depends on 33)

The process according to claim 33, wherein the amino ketal compound is selected from (2-methyl-1,3-dioxolan-2-yl)methanamine, (2,5,5-trimethyl-1,3-dioxan-2-yl)methanamine or 1-amino-2,2-dimethoxypropane.

### Claim 35 (depends on 33)

The process according to claim 33, wherein the amino ketal is 1-amino-2,2-dimethoxypropane.

### Claim 36 (depends on 33)

The process according to claim 33, wherein the carbonyl activating group is selected from triflic anhydride, triflic acid, benzene sulfonic acid, Toluene sulfonic acid, or Methane sulfonic acid.

### Claim 37 (depends on 33)

The process according to claim 33, wherein the process is a one-pot process.

### Claim 38

A process for preparation of Remimazolam comprising:
a. reacting a compound of formula IV-A:
and amino-alcohol in the presence of triflic anhydride and halopyridine to obtain a compound of formula II-A of the following structure:
wherein R3 and R4 are independently H, alkyl, acyl, vinyl or allyl,
X is any halogen,
Y is O, S or N,
A is alkyl or aliphatic, aromatic or heterocyclic ring, and
Pg1 is H or any hydroxyl protecting group;
b. converting the compound of formula II-A to a compound of formula I-A:
and
c. optionally, converting the compound of formula I-A to Remimazolam.

### Claim 39 (depends on 38)

The process according to claim 38, wherein the amino alcohol is 1-Aminopropan-2-ol.

### Claim 40 (depends on 38)

The process according to claim 38 wherein Y is O, R3 is C1 alkyl, X is Br and A is 2-pyridinyl.

### Claim at position 21

41-58. (canceled)
